Avidity Biosciences (NASDAQ:RNA) reported quarterly losses of $(0.88) per share which beat the analyst consensus estimate of $(0.89) by 1.12 percent. This is a 7.32 percent decrease over losses of $(0.82) per share from
GoodRx (NASDAQ:GDRX), America's digital resource for healthcare, today launched GoodRx Health to provide research-based answers to vital health questions. Unlike other consumer health destinations,